EA&FLUM: Electro-acupuncture and Flumazenil's Effect on Sedation

Sponsor
Dr. Yin Liu (Other)
Overall Status
Completed
CT.gov ID
NCT02690389
Collaborator
Sichuan Cancer Hospital and Research Institute (Other)
80
1
4
7
11.5

Study Details

Study Description

Brief Summary

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system.

Method: 80 patients undergoing abdominal surgery were randomly divided into four groups (n=20): C group (propofol only group), F group (propofol + flumazenil group), EA group (propofol + electro-acupuncture group), and EA+F group (propofol + electro-acupuncture + flumazenil group). Before induction, acupuncture needles were inserted at the points of Zusanli (ST 36) and Neiguan (PC 6) bilaterally to elicit"DeQi". Target-controlled infusion (TCI) of propofol was used for the induction and maintenance of anaesthesia. After 15minutes, equilibrium of Narcotrend Index (NT index) was achieved, patients were then assigned to receive different interventions. In EA group and EA+F group, patients received EA for 30 minutes under general anaesthesia, and flumazenil with the dosage of 0.1mg/kg was added in the latter at the end of EA. In C group and F group, patients didn't receive EA, and flumazenil with the dosage of 0.1mg/kg was administered in F Group at the same time point with EA+F group. HR, MAP and NT index were recorded at different time points up to 30 minutes after the end of EA.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Sedation Effect of Electro-acupuncture on Bilateral Zusanli (ST 36) and Neiguan (PC 6) in General Anesthesia May Not be Mediated by the Benzodiazepines- GABA Pathway
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

standard procedure is used

Sham Comparator: Flumazenil only group

flumazenil is given

Drug: Flumazenil
used alone or with acupuncture

Active Comparator: control with acupuncture

control with acupuncture

Procedure: Acupuncture
used alone or with flumazenil

Active Comparator: control with acupuncture and flumazenil

control with acupuncture and flumazenil

Drug: Flumazenil
used alone or with acupuncture

Procedure: Acupuncture
used alone or with flumazenil

Outcome Measures

Primary Outcome Measures

  1. depth of general anaesthesia [2 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 80 abdominal surgical patients

  • aged 30 to 60 years old,

  • weighing 50-70Kg,

  • ASA I-Ⅱ, who scheduled to receive general anaesthesia were enrolled to this trial.

Exclusion Criteria:
  • Hypertension or severe heart and lung diseases,

  • Conditions that might affect the consciousness or NT index, such as seizures, psychosis, brain lesions, and treatment with sedative drugs,

  • Contraindications to acupuncture, such as severe hemorrhagic disease, hyper-sensitive patient, and tumor or ulcer exist on the skin of the acupuncture points.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sichuan Cancer Hospital Chengdu Sichuan China 610000

Sponsors and Collaborators

  • Dr. Yin Liu
  • Sichuan Cancer Hospital and Research Institute

Investigators

  • Principal Investigator: yin liu, PhD, Sichuan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Yin Liu, Associate Professor, Chief of Clinical Research, Sichuan Cancer Hospital and Research Institute
ClinicalTrials.gov Identifier:
NCT02690389
Other Study ID Numbers:
  • SiChuanCHRI001
First Posted:
Feb 24, 2016
Last Update Posted:
Feb 24, 2016
Last Verified:
Feb 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Dr. Yin Liu, Associate Professor, Chief of Clinical Research, Sichuan Cancer Hospital and Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 24, 2016